PURPOSE: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). PATIENTS AND METHODS: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. RESULTS: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Nonwhite males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to.001). CONCLUSION: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.
PURPOSE: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). PATIENTS AND METHODS: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. RESULTS:Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Nonwhite males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to.001). CONCLUSION: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.
Authors: Robin L Seitzman; Dorie A Glover; Anna T Meadows; James L Mills; H Stacy Nicholson; Leslie L Robison; Julianne Byrne; Lonnie K Zeltzer Journal: Pediatr Blood Cancer Date: 2004-03 Impact factor: 3.167
Authors: Laura K Campbell; Mary Scaduto; Deborah Van Slyke; Frances Niarhos; James A Whitlock; Bruce E Compas Journal: J Pediatr Psychol Date: 2008-07-30
Authors: Kevin C Oeffinger; Melissa M Hudson; Ann C Mertens; Stephanie M Smith; Pauline A Mitby; Debra A Eshelman-Kent; Jennifer S Ford; Judith K Jones; Sharmila Kamani; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2010-12-16 Impact factor: 3.167
Authors: Stephen A Sands; Keith P Pasichow; Rebecca Weiss; James Garvin; Sharon Gardner; Ira J Dunkel; Jonathan L Finlay Journal: J Neurooncol Date: 2010-06-06 Impact factor: 4.130
Authors: Amy M Berkman; Abenaa M Brewster; Lee W Jones; Jun Yu; J Jack Lee; S Andrew Peng; Abigail Crocker; Joann L Ater; Susan C Gilchrist Journal: J Adolesc Young Adult Oncol Date: 2017-05-22 Impact factor: 2.223
Authors: Stephen Alan Sands; Tianni Zhou; Sharon Helene O'Neil; Sunita K Patel; Jeffrey Allen; Patsy McGuire Cullen; Thomas A Kaleita; Robert Noll; Charles Sklar; Jonathan Lester Finlay Journal: J Clin Oncol Date: 2012-02-21 Impact factor: 44.544